Brookdale (BKD) Q2 Earnings Report Preview: What To Look For

August 04, 2025 at 23:12 PM EDT

BKD Cover Image

Senior living provider Brookdale Senior Living (NYSE: BKD) will be announcing earnings results this Wednesday afternoon. Here’s what to expect.

Brookdale met analysts’ revenue expectations last quarter, reporting revenues of $813.9 million, up 4% year on year. It was a slower quarter for the company, with a significant miss of analysts’ EPS estimates.

Is Brookdale a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Brookdale’s revenue to grow 5.2% year on year to $817.6 million, improving from the 3.6% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.14 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Brookdale has missed Wall Street’s revenue estimates five times over the last two years.

Looking at Brookdale’s peers in the senior health, home health & hospice segment, some have already reported their Q2 results, giving us a hint as to what we can expect. BrightSpring Health Services delivered year-on-year revenue growth of 15.3%, beating analysts’ expectations by 5.2%, and Option Care Health reported revenues up 15.4%, topping estimates by 4.6%. BrightSpring Health Services traded down 6.1% following the results while Option Care Health was also down 2.7%.

Read our full analysis of BrightSpring Health Services’s results here and Option Care Health’s results here.

Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the senior health, home health & hospice stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3.3% on average over the last month. Brookdale is up 15.5% during the same time and is heading into earnings with an average analyst price target of $8 (compared to the current share price of $7.73).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

About Us

Additional Information

Website & Technical Help

Brookdale (BKD) Q2 Earnings Report Preview: What To Look For

More News